Whole Person Healing.
For All.

Sunstone is redefining what it means to heal by creating a safe and compassionate setting for the delivery of psychedelic-assisted therapy within a medical framework. With a range of clinical trials, a highly-trained interdisciplinary team, and purposely designed centers, we are committed to treating the whole person.
Explore Our Clinical Trials

Pioneering a New Era
in Modern Medicine

Sunstone Therapies is a leader in the delivery of psychedelic-assisted therapy in the medical setting, focusing on clinical trials and future clinical delivery upon approval.
Psychedelic-Assisted Therapy
Learn More
Clinical Trials
Learn More
Published Research
Learn More
Patient Experience
Centers for Healing
Learn More
Partnerships
Learn More
Patient Support Resources
Learn More

Expertise Informed by Experience

Learn More

Sunstone is guided by a team of Clinical Research Coordinators with over 30 years of combined clinical expertise and over 5 years of specialized experience in psychedelic research.

6
Psychedelic Compounds
Psilocybin
MDMA
LSD
5-MeO-DMT
Methylone
RE104 (serotonergic antidepressant)
8
Treatment Indications
PTSD (Post-Traumatic Stress Disorder)
MDD (Major Depressive Disorder)
TRD (Treatment-Resistant Depression)
GAD (Generalized Anxiety Disorder)
AD (Adjustment Disorder)
Postpartum Depression
Palliative Care (End of Life)
Cancer & MDD
7
Open Studies
Our Mission

Our Mission

Sunstone is establishing the gold standard for psychedelic clinics to deliver care that reduces the emotional suffering of those affected by complex mental health challenges and disorders, and to make safe, effective psychedelic-assisted therapy accessible.
Whole Person Healing is

Sunstone in the News

Sunstone Therapies Co-Founder and CEO Dr. Manish Agrawal Appointed to State of Maryland’s Task Force on Responsible Use of Natural Psychedelic Substances

October 22, 2024 Sunstone Therapies is pleased to announce that Dr. Manish Agrawal was appointed by Maryland Governor Wes Moore […]

Learn More
The Power of the Group in Psychedelic-Assisted Therapy

Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.

Learn More
How to Treat Cancer in Its Entirety

Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.

Learn More
Letter from Sunstone CEO Manish Agrawal, MD: Perspectives on Recent News and Key Considerations for Psychedelic-Assisted Therapy

Dear Sunstone Community, It has been a pivotal couple of weeks for the field of psychedelic-assisted therapy (PAT) following the […]

Learn More
Psychedelics: Subjectivity in the Therapeutic Response

Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.

Learn More
How Psychedelics Can Unlock New Care in Oncology

Dr. Manish Agrawal speaks PATs ability to treat not just the physical manifestations of cancer but also the mental and emotional toll it takes on patients.

Learn More
Why Psychedelic Therapy Needs Specially Trained Therapists

Enhanced therapist training standards are necessary, along with an additional PAT therapists.

Learn More
How to Change Your Mind on Netflix

Explore the healing powers of psychedelics in ‘How to Change Your Mind’—a 4-part series based on Michael Pollan’s book.

Learn More
How Do Psychedelic Treatments Work?

Learn about psychedelic therapy in this WebMD article that unpacks MOAs of psychedelic medicines & their potential in mental health treatment.

Learn More
Publication of Positive Data on Use of Psilocybin Therapy for Patients with Cancer and Major Depression Disorder, in JAMA Oncology

Sunstone Therapies announces publication of positive data on use of Psilocybin Therapy for patients with cancer and major depression disorder

Learn More